Indication

Female facial hirsutism

Female facial hirsutism is an endocrine and dermatologic manifestation characterized by excessive, male-pattern growth of coarse, pigmented terminal hair on androgen-dependent areas of a female patient's face, most notably the upper lip, chin, and jawline. Read more about Female facial hirsutism

2 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Female facial hirsutism therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Female facial hirsutism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Female facial hirsutism.

Female facial hirsutism is an endocrine and dermatologic manifestation characterized by excessive, male-pattern growth of coarse, pigmented terminal hair on androgen-dependent areas of a female patient's face, most notably the upper lip, chin, and jawline.

The condition arises from androgen excess—predominantly associated with underlying disorders such as polycystic ovary syndrome or nonclassic adrenal hyperplasia—or from increased follicular sensitivity to circulating androgens mediated by 5-alpha reductase activity.

Pathophysiologically, localized androgen exposure alters the hair cycle and stimulates the transformation of fine, non-pigmented vellus hairs into thicker, darker terminal hairs.

It affects postpubertal and adult females, presenting either as an isolated idiopathic complaint or as a cardinal clinical sign of systemic hyperandrogenism.

Personalize your experience

Follow Female facial hirsutism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it